Company Overview and News

2
Z Energy (ZNRGF) Investor Presentation - Slideshow

2018-06-21 seekingalpha
The following slide deck was published by Z ENERGY LTD ORD in conjunction with this event.
ZNZ ZNRGF ZEL

2
Z Energy eyes car-sharing start-ups and parcel collection

2018-06-21 nzherald.co.nz
Z Energy is a petrol retailer in an increasingly unwelcoming world. And as fossil fuels fall further out of favour, it's looking to car-sharing start-ups and parcel collection in its next evolution.
ZNZ ZNRGF ZEL

10
MARKET WRAP: NZ shares slip after strong run

2018-06-18 nbr.co.nz
The New Zealand market was flat today ahead of several key data points later in the week.
AIA FBU FCREY ZNRGF ACKDF FRCEF ZEL AUKNY ZNZ AIA PPSHY FBU PFGTF

2
Sharemarket overvalued, rally hard to justify - Forsyth Barr

2018-06-10 nzherald.co.nz
The sharemarket looks over valued as investors fail to price in uncertainty from the new Government's policies and rising costs, says brokers Forsyth Barr.
ZNZ MPP ZNRGF MTPGF ZEL AUG

8
Air New Zealand's Christopher Luxon: My toughest year

2018-06-01 nzherald.co.nz
Since he took over the top job at Air New Zealand in 2013, it's been a great run for Christopher Luxon.
ZNZ ANZLY AIR ZNRGF ANZFF ANZFY ZEL AIZ

14
Shares fall in light trading after index reweighting

2018-06-01 nzherald.co.nz
New Zealand shares fell in more subdued trading following yesterday's billion-dollar MSCI rebalancing, with A2 Milk Co and Synlait dropping while Air New Zealand gained.
CEN AIR ZNRGF ZEL ANZFY COENY AIZ COENF ZNZ ANZLY CEN ANZFF MEZ SML

2
Z Energy goes from 2.5 million plastic carrier bags for customers to zero

2018-06-01 nzherald.co.nz
The service stations stopped providing plastic bags to customers on Friday, June 1, after phasing them out over the past six months. Z previously provided about 2.5 million plastic bags per year.
ZNZ ZNRGF ZEL

2
'It's a lot to ask of motorists': AA says new fuel taxes need to deliver results for Auckland

2018-05-31 nzherald.co.nz
The AA is warning the public mood will turn "really dark" if Auckland motorists aren't seeing any benefits of the regional fuel tax by the end of the year.
ZNZ ZNRGF ZEL

4
NZ shares drop as A2 extends slide

2018-05-29 nzherald.co.nz
New Zealand shares fell as A2 Milk extended its decline and Fisher & Paykel Healthcare and Scales Corp droped while Synlait Milk and Mainfreight rose.
ZNZ ZNRGF GTK ZEL KWIPF PFGTF SML

2
Invenco wins top company in Hi-Tech Awards

2018-05-27 nbr.co.nz
Invenco won the PwC Hi-Tech Company of the Year at the annual Hi-Tech awards held in Christchurch, with the international judges saying it “prevailed with its unique combination of extraordinary growth, scale and profitability.”
ZNZ ZNRGF ZEL

2
Petrol prices hit record levels on the road to $2.30 a litre

2018-05-21 nzherald.co.nz
A petrol retailer claims little more can be done to make petrol cheaper at the pump. Prices in some parts of the country are at their highest levels at just under $2.30 a litre for 91 octane.
ZNZ ZNRGF ZEL

23
Shares gain as Ryman posts record profit

2018-05-18 nzherald.co.nz
New Zealand shares rose as Goodman Property Trust's joint venture with GIC sold seven buildings in downtown Auckland, and as Ryman Healthcare chalked up another record profit. A2 Milk Co and Comvita fell.
AIA FBU RHCGF FCREY SPKKY NZTCY ZNRGF SPK NZTCF RYM ACKDF FRCEF ZEL AUKNY ZNZ AIA FBU RYHTY MEZ

8
Stock Takes: A2 fall shows NZ's frailty

2018-05-17 nzherald.co.nz
A2 Milk's plunge on Wednesday shows just how exposed the New Zealand market can be to one stock.
ZNZ FBU FBU FCREY ZNRGF FRCEF ZEL

2
Supermarket chain Foodstuffs admits facial recognition technology used in some stores

2018-05-13 nzherald.co.nz
New Zealand's largest supermarket company has quietly rolled out facial recognition CCTV technology in some of its North Island stores.
ZNZ ZNRGF ZEL

2
Comment: Super Fund should not be Auckland's cash cow

2018-05-09 nzherald.co.nz
Is an unexpected white knight riding into Auckland, weaving through the chronic congestion of a city bursting at the seams?
ZNZ ZNRGF ZEL

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...